That hasn’t stopped Ovid Therapeutics from pressing ahead with first-in-class therapies for challenging brain disorders. Since its 2014 launch, Ovid has maintained a particularly staunch commitment to ...

Within days of release, Clawdbot became a sensation, delivering both the promise of productivity and a security nightmare, while giving a glimpse of our agent-run future writes Satyen K. Bordoloi ...